BEAM THERAPEUTICS INC (BEAM) Stock Cash Flow
NASDAQ:BEAM - Nasdaq - US07373V1052 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -387.34M | -376.74M | -132.53M | -289.09M | -370.64M | |||
| Depreciation Amortization | 22.02M | 21.93M | 20.01M | 14.15M | 7.45M | |||
| Change In Working Capital | -97.73M | -110.22M | -116.45M | 251.63M | 111.25M | |||
| Interest Paid | 18.00K | 32.00K | 160.00K | 380.00K | 570.00K | |||
| Other non cash items | 111.67M | 117.79M | 79.78M | 45.84M | 185.67M | |||
| OPERATING CASH FLOW | -351.38M | -347.25M | -149.19M | 22.53M | -66.27M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -9.57M | -8.95M | -33.73M | -48.95M | -46.81M | |||
| Other Investing Activity | 122.95M | 193.95M | 105.57M | -412.39M | -247.33M | |||
| INVESTING CASH FLOW | 113.38M | 185.01M | 71.84M | -461.34M | -294.14M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -308.00K | -485.00K | -2.25M | -2.29M | -2.12M | |||
| Stock Issued/Repurchased | 478.53M | 8.22M | 279.33M | 114.07M | 767.08M | |||
| Other Financing Activity | N/A | 0.00 | -631.00K | -190.00K | -8.82M | |||
| FINANCING CASH FLOW | 478.22M | 7.74M | 276.45M | 111.59M | 756.14M | |||
| CHANGE IN CASH | 240.22M | -154.50M | 199.09M | -327.22M | 395.73M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -351.38M | -347.25M | -149.19M | 22.53M | -66.27M | |||
| Capital Expenditure | -9.57M | -8.95M | -33.73M | -48.95M | -46.81M | |||
| FREE CASH FLOW | -360.96M | -356.19M | -182.93M | -26.42M | -113.08M | |||
All data in USD